Abstract 15685: Selective Improvement of Pulmonary Arterial Hypertension With Dual ETA/ETB Receptors Antagonist in the Apolipoprotein E-/- Model of PAH and Atherosclerosis
Circulation(2016)
摘要
Introduction: Pulmonary arterial hypertension (PAH) is a devastating condition and without treatment is associated with a life expectancy of 2.8 years. Apolipoprotein E deficient (ApoE-/-) mice dev...
更多查看译文
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要